img

Global Antifungal infection Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Antifungal infection Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.
Global Antifungal infection Therapeutics market is projected to reach US$ 29440 million in 2033, increasing from US$ 18650 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2033. Demand from Hospitals and Clinics and Dermatology Clinic are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Antifungal infection Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Glaxosmithkline
Enzon Pharmaceuticals
Bayer Healthcare
Astellas Pharma
Asperqillus
Alternaria
Abbott Laboratories
Segment by Type
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types

Segment by Application


Hospitals and Clinics
Dermatology Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antifungal infection Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Antifungal infection Therapeutics introduction, etc. Antifungal infection Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Antifungal infection Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Antifungal infection Therapeutics
1.1 Antifungal infection Therapeutics Market Overview
1.1.1 Antifungal infection Therapeutics Product Scope
1.1.2 Antifungal infection Therapeutics Market Status and Outlook
1.2 Global Antifungal infection Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Antifungal infection Therapeutics Market Size by Region (2018-2033)
1.4 Global Antifungal infection Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Antifungal infection Therapeutics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Antifungal infection Therapeutics Market Size (2018-2033)
1.6.1 North America Antifungal infection Therapeutics Market Size (2018-2033)
1.6.2 Europe Antifungal infection Therapeutics Market Size (2018-2033)
1.6.3 Asia-Pacific Antifungal infection Therapeutics Market Size (2018-2033)
1.6.4 Latin America Antifungal infection Therapeutics Market Size (2018-2033)
1.6.5 Middle East & Africa Antifungal infection Therapeutics Market Size (2018-2033)
2 Antifungal infection Therapeutics Market by Type
2.1 Introduction
2.1.1 Polyenes
2.1.2 Echinocandins
2.1.3 Azoles
2.1.4 Allylamines
2.1.5 Other Drug types
2.2 Global Antifungal infection Therapeutics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Antifungal infection Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Antifungal infection Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Antifungal infection Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Antifungal infection Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Antifungal infection Therapeutics Revenue Breakdown by Type (2018-2033)
3 Antifungal infection Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Dermatology Clinic
3.2 Global Antifungal infection Therapeutics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Antifungal infection Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Antifungal infection Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Antifungal infection Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Antifungal infection Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Antifungal infection Therapeutics Revenue Breakdown by Application (2018-2033)
4 Antifungal infection Therapeutics Competition Analysis by Players
4.1 Global Antifungal infection Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
4.3 Date of Key Players Enter into Antifungal infection Therapeutics Market
4.4 Global Top Players Antifungal infection Therapeutics Headquarters and Area Served
4.5 Key Players Antifungal infection Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Antifungal infection Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Scynexis
5.1.1 Scynexis Profile
5.1.2 Scynexis Main Business
5.1.3 Scynexis Antifungal infection Therapeutics Products, Services and Solutions
5.1.4 Scynexis Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Scynexis Recent Developments
5.2 Sanofi-Aventis
5.2.1 Sanofi-Aventis Profile
5.2.2 Sanofi-Aventis Main Business
5.2.3 Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
5.2.4 Sanofi-Aventis Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi-Aventis Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Antifungal infection Therapeutics Products, Services and Solutions
5.3.4 Pfizer Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Antifungal infection Therapeutics Products, Services and Solutions
5.4.4 Novartis Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Merck & Co
5.5.1 Merck & Co Profile
5.5.2 Merck & Co Main Business
5.5.3 Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
5.5.4 Merck & Co Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck & Co Recent Developments
5.6 Kramer Laboratories
5.6.1 Kramer Laboratories Profile
5.6.2 Kramer Laboratories Main Business
5.6.3 Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
5.6.4 Kramer Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Kramer Laboratories Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
5.7.4 Johnson & Johnson Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Recent Developments
5.8 ID Sigma-Aldrich Corporation
5.8.1 ID Sigma-Aldrich Corporation Profile
5.8.2 ID Sigma-Aldrich Corporation Main Business
5.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
5.8.4 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 ID Sigma-Aldrich Corporation Recent Developments
5.9 Glenmark Pharmaceuticals
5.9.1 Glenmark Pharmaceuticals Profile
5.9.2 Glenmark Pharmaceuticals Main Business
5.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
5.9.4 Glenmark Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Glenmark Pharmaceuticals Recent Developments
5.10 Glaxosmithkline
5.10.1 Glaxosmithkline Profile
5.10.2 Glaxosmithkline Main Business
5.10.3 Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
5.10.4 Glaxosmithkline Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Glaxosmithkline Recent Developments
5.11 Enzon Pharmaceuticals
5.11.1 Enzon Pharmaceuticals Profile
5.11.2 Enzon Pharmaceuticals Main Business
5.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
5.11.4 Enzon Pharmaceuticals Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Enzon Pharmaceuticals Recent Developments
5.12 Bayer Healthcare
5.12.1 Bayer Healthcare Profile
5.12.2 Bayer Healthcare Main Business
5.12.3 Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
5.12.4 Bayer Healthcare Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Bayer Healthcare Recent Developments
5.13 Astellas Pharma
5.13.1 Astellas Pharma Profile
5.13.2 Astellas Pharma Main Business
5.13.3 Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
5.13.4 Astellas Pharma Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Astellas Pharma Recent Developments
5.14 Asperqillus
5.14.1 Asperqillus Profile
5.14.2 Asperqillus Main Business
5.14.3 Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
5.14.4 Asperqillus Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.14.5 Asperqillus Recent Developments
5.15 Alternaria
5.15.1 Alternaria Profile
5.15.2 Alternaria Main Business
5.15.3 Alternaria Antifungal infection Therapeutics Products, Services and Solutions
5.15.4 Alternaria Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.15.5 Alternaria Recent Developments
5.16 Abbott Laboratories
5.16.1 Abbott Laboratories Profile
5.16.2 Abbott Laboratories Main Business
5.16.3 Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
5.16.4 Abbott Laboratories Antifungal infection Therapeutics Revenue (US$ Million) & (2018-2023)
5.16.5 Abbott Laboratories Recent Developments
6 North America
6.1 North America Antifungal infection Therapeutics Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Antifungal infection Therapeutics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antifungal infection Therapeutics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antifungal infection Therapeutics Market Dynamics
11.1 Antifungal infection Therapeutics Industry Trends
11.2 Antifungal infection Therapeutics Market Drivers
11.3 Antifungal infection Therapeutics Market Challenges
11.4 Antifungal infection Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Antifungal infection Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Antifungal infection Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Antifungal infection Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Antifungal infection Therapeutics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Antifungal infection Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Antifungal infection Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Antifungal infection Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Antifungal infection Therapeutics Revenue Market Share by Type (2024-2033)
Table 11. North America Antifungal infection Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Antifungal infection Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Antifungal infection Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Antifungal infection Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Antifungal infection Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Antifungal infection Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Antifungal infection Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Antifungal infection Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Antifungal infection Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Antifungal infection Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Antifungal infection Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Antifungal infection Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Antifungal infection Therapeutics Revenue Market Share by Application (2024-2033)
Table 26. North America Antifungal infection Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Antifungal infection Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Antifungal infection Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Antifungal infection Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Antifungal infection Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Antifungal infection Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Antifungal infection Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Antifungal infection Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Antifungal infection Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Antifungal infection Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Antifungal infection Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antifungal infection Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Antifungal infection Therapeutics Market
Table 40. Global Antifungal infection Therapeutics Key Players Headquarters and Area Served
Table 41. Antifungal infection Therapeutics Product Solution and Service
Table 42. Global Antifungal infection Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Scynexis Basic Information List
Table 45. Scynexis Description and Business Overview
Table 46. Scynexis Antifungal infection Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Scynexis (2018-2023)
Table 48. Scynexis Recent Developments
Table 49. Sanofi-Aventis Basic Information List
Table 50. Sanofi-Aventis Description and Business Overview
Table 51. Sanofi-Aventis Antifungal infection Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Sanofi-Aventis (2018-2023)
Table 53. Sanofi-Aventis Recent Developments
Table 54. Pfizer Basic Information List
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Antifungal infection Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Pfizer (2018-2023)
Table 58. Pfizer Recent Developments
Table 59. Novartis Basic Information List
Table 60. Novartis Description and Business Overview
Table 61. Novartis Antifungal infection Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Novartis (2018-2023)
Table 63. Novartis Recent Developments
Table 64. Merck & Co Basic Information List
Table 65. Merck & Co Description and Business Overview
Table 66. Merck & Co Antifungal infection Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Merck & Co (2018-2023)
Table 68. Merck & Co Recent Developments
Table 69. Kramer Laboratories Basic Information List
Table 70. Kramer Laboratories Description and Business Overview
Table 71. Kramer Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Kramer Laboratories (2018-2023)
Table 73. Kramer Laboratories Recent Developments
Table 74. Johnson & Johnson Basic Information List
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Antifungal infection Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Johnson & Johnson (2018-2023)
Table 78. Johnson & Johnson Recent Developments
Table 79. ID Sigma-Aldrich Corporation Basic Information List
Table 80. ID Sigma-Aldrich Corporation Description and Business Overview
Table 81. ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Antifungal infection Therapeutics Business of ID Sigma-Aldrich Corporation (2018-2023)
Table 83. ID Sigma-Aldrich Corporation Recent Developments
Table 84. Glenmark Pharmaceuticals Basic Information List
Table 85. Glenmark Pharmaceuticals Description and Business Overview
Table 86. Glenmark Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glenmark Pharmaceuticals (2018-2023)
Table 88. Glenmark Pharmaceuticals Recent Developments
Table 89. Glaxosmithkline Basic Information List
Table 90. Glaxosmithkline Description and Business Overview
Table 91. Glaxosmithkline Antifungal infection Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Glaxosmithkline (2018-2023)
Table 93. Glaxosmithkline Recent Developments
Table 94. Enzon Pharmaceuticals Basic Information List
Table 95. Enzon Pharmaceuticals Description and Business Overview
Table 96. Enzon Pharmaceuticals Antifungal infection Therapeutics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Enzon Pharmaceuticals (2018-2023)
Table 98. Enzon Pharmaceuticals Recent Developments
Table 99. Bayer Healthcare Basic Information List
Table 100. Bayer Healthcare Description and Business Overview
Table 101. Bayer Healthcare Antifungal infection Therapeutics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Bayer Healthcare (2018-2023)
Table 103. Bayer Healthcare Recent Developments
Table 104. Astellas Pharma Basic Information List
Table 105. Astellas Pharma Description and Business Overview
Table 106. Astellas Pharma Antifungal infection Therapeutics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Astellas Pharma (2018-2023)
Table 108. Astellas Pharma Recent Developments
Table 109. Asperqillus Basic Information List
Table 110. Asperqillus Description and Business Overview
Table 111. Asperqillus Antifungal infection Therapeutics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Asperqillus (2018-2023)
Table 113. Asperqillus Recent Developments
Table 114. Alternaria Basic Information List
Table 115. Alternaria Description and Business Overview
Table 116. Alternaria Antifungal infection Therapeutics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Alternaria (2018-2023)
Table 118. Alternaria Recent Developments
Table 119. Abbott Laboratories Basic Information List
Table 120. Abbott Laboratories Description and Business Overview
Table 121. Abbott Laboratories Antifungal infection Therapeutics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Antifungal infection Therapeutics Business of Abbott Laboratories (2018-2023)
Table 123. Abbott Laboratories Recent Developments
Table 124. North America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 125. North America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 126. Europe Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 127. Europe Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 128. Asia-Pacific Antifungal infection Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 129. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 130. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 131. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2018-2023)
Table 132. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2024-2033)
Table 133. Latin America Antifungal infection Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 134. Latin America Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 135. Latin America Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 136. Middle East & Africa Antifungal infection Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 137. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 138. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 139. Antifungal infection Therapeutics Market Trends
Table 140. Antifungal infection Therapeutics Market Drivers
Table 141. Antifungal infection Therapeutics Market Challenges
Table 142. Antifungal infection Therapeutics Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antifungal infection Therapeutics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Antifungal infection Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Antifungal infection Therapeutics Market Share by Regions: 2022 VS 2033
Figure 4. Global Antifungal infection Therapeutics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Antifungal infection Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Antifungal infection Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Antifungal infection Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Antifungal infection Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Antifungal infection Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Polyenes
Figure 11. Global Polyenes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Echinocandins
Figure 13. Global Echinocandins Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Azoles
Figure 15. Global Azoles Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Allylamines
Figure 17. Global Allylamines Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Product Picture of Other Drug types
Figure 19. Global Other Drug types Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 20. Global Antifungal infection Therapeutics Market Size Share by Type: 2022 & 2033
Figure 21. North America Antifungal infection Therapeutics Revenue Market Share by Type (2018-2033)
Figure 22. Europe Antifungal infection Therapeutics Revenue Market Share by Type (2018-2033)
Figure 23. Asia-Pacific Antifungal infection Therapeutics Revenue Market Share by Type (2018-2033)
Figure 24. Latin America Antifungal infection Therapeutics Revenue Market Share by Type (2018-2033)
Figure 25. Middle East and Africa Antifungal infection Therapeutics Revenue Market Share by Type (2018-2033)
Figure 26. Hospitals and Clinics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Dermatology Clinic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Global Antifungal infection Therapeutics Market Size Share by Application: 2022 & 2033
Figure 29. North America Antifungal infection Therapeutics Revenue Market Share by Application (2018-2033)
Figure 30. Europe Antifungal infection Therapeutics Revenue Market Share by Application (2018-2033)
Figure 31. Asia-Pacific Antifungal infection Therapeutics Revenue Market Share by Application (2018-2033)
Figure 32. Latin America Antifungal infection Therapeutics Revenue Market Share by Application (2018-2033)
Figure 33. Middle East and Africa Antifungal infection Therapeutics Revenue Market Share by Application (2018-2033)
Figure 34. Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 35. Global Top 5 and Top 10 Players Antifungal infection Therapeutics Market Share in 2022
Figure 36. North America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 37. U.S. Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 38. Canada Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 39. Germany Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 40. France Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 41. U.K. Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 42. Italy Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 43. Russia Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 44. Nordic Countries Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 45. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2018-2033)
Figure 46. China Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 47. Japan Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 48. South Korea Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 49. Southeast Asia Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 50. India Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 51. Australia Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 52. Latin America Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 53. Mexico Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 54. Brazil Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 55. Middle East & Africa Antifungal infection Therapeutics Market Share by Country (2018-2033)
Figure 56. Turkey Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 58. UAE Antifungal infection Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report